SARS-CoV-2 Infection Does Not Impact Symptoms, Treatment Of Patients With Hemophilia, Study Suggests

Infectious Disease Advisor (10/3, Lai) reports, “SARS-CoV-2 infection did not significantly impact the symptoms of patients with hemophilia and their treatment, according to a study.” The researchers said, “The findings of this study showed that the COVID-19 pandemic did not affect patients with mild or higher grades of hemophilia and had no significant effect on bleeding symptoms, factor therapy levels, and bleeding sites.” The findings were published in the Annals of Hematology.